The prevalence of atherogenic forms of apolipoprotein B dyslipoproteinemias is high, but effective treatments are available. Quick, accurate diagnosis is, therefore, essential to providing the best care. In this Review an algorithm is proposed to help distinguish between disease subtypes, based on simple parameters that may be measured by low-cost tests widely available in clinical laboratories.
- Jacqueline de Graaf
- Patrick Couture
- Allan Sniderman
